Insider · CIK 0001891888
Blake Gurfein
Files at VBIO (Valion Bio, Inc.). First filing -, latest -.
In brief
Blake Gurfein files SEC Form 4 as officer at VBIO (Valion Bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Blake Gurfein has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2024 | VBIO Valion Bio, Inc. | AGrant or award Restricted Stock Unitsderivative | +225,000 | $0.00 | $0 | 225,000 | Dec 20, 2024 |
Questions about Blake Gurfein
Answered from the filings on this page, as of the latest one.
Is Blake Gurfein buying or selling?
Blake Gurfein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Blake Gurfein's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Blake Gurfein has 0.
Where does Blake Gurfein file Form 4?
Blake Gurfein has filed Form 4 at VBIO (Valion Bio, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.